Vertex Pharmaceuticals (VRTX) Assets: 2009-2025
Historic Assets for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Sep 2025 value amounting to $24.9 billion.
- Vertex Pharmaceuticals' Assets rose 11.79% to $24.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 billion, marking a year-over-year increase of 11.79%. This contributed to the annual value of $22.5 billion for FY2024, which is 0.87% down from last year.
- According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Assets is $24.9 billion, which was up 3.43% from $24.0 billion recorded in Q2 2025.
- Vertex Pharmaceuticals' 5-year Assets high stood at $24.9 billion for Q3 2025, and its period low was $12.1 billion during Q1 2021.
- Moreover, its 3-year median value for Assets was $22.5 billion (2024), whereas its average is $22.2 billion.
- Per our database at Business Quant, Vertex Pharmaceuticals' Assets spiked by 36.23% in 2021 and then fell by 4.34% in 2025.
- Quarterly analysis of 5 years shows Vertex Pharmaceuticals' Assets stood at $13.4 billion in 2021, then surged by 35.13% to $18.2 billion in 2022, then rose by 25.23% to $22.7 billion in 2023, then fell by 0.87% to $22.5 billion in 2024, then climbed by 11.79% to $24.9 billion in 2025.
- Its Assets was $24.9 billion in Q3 2025, compared to $24.0 billion in Q2 2025 and $22.9 billion in Q1 2025.